U.S. Retail Distributors Stock News

If you are wondering whether Globant's current share price reflects its true worth, you are not alone. This article is here to unpack that question in a clear, practical way. The stock last closed at US$68.39, with returns of 8.4% over the past week, a 0.8% decline over 30 days, 8.4% year to date, and declines of 67.0% over 1 year, 59.4% over 3 years, and 67.2% over 5 years. These moves have put Globant back on many investors' watchlists, as the sharp multi year pullback sits alongside a...

Wondering if Jazz Pharmaceuticals is still offering value at around US$161 a share, or if most of the opportunity has already been priced in? The stock is up 32.7% over the past year, even though it has seen a 6.9% decline over the last week and a 2.3% decline over the past month. Recent attention on Jazz Pharmaceuticals has centered on its position in pharmaceuticals and biotech, with investors weighing the company against sector peers and sentiment around the broader drug development...

Scholar Rock Holding (SRRK) has drawn investor attention after recent share price moves, with the stock last closing at US$42.18. That price sits against a mixed return profile across the past month and the past 3 months. See our latest analysis for Scholar Rock Holding. Looking past the recent pullback, Scholar Rock Holding’s 30 day share price return of a 6.37% decline contrasts with a 6.89% gain over 90 days. The 3 year total shareholder return of about 3.5x suggests momentum has broadly...

If you are wondering whether Pure Storage is still reasonably priced after its long run as a data storage name, it helps to step back and look at how the current share price lines up with its fundamentals. The stock last closed at US$66.98, with returns of 3.5% over the past year, a 153.1% gain over 3 years and 193.0% over 5 years. The more recent 7 day and 30 day moves of 2.9% and 9.1% declines hint at shifting expectations and risk perceptions in the short term. Recent attention on Pure...

PROCEPT BioRobotics (PRCT) is back in focus after a flurry of analyst updates, including a downgrade from Bank of America that sits alongside more optimistic views on future utilization and long-term market potential. See our latest analysis for PROCEPT BioRobotics. The recent analyst flurry comes after a choppy stretch for PROCEPT BioRobotics, with a 7 day share price return of 6.73% following a 1 day decline of 4.79% and a 1 year total shareholder return of 62.20% in the red. This suggests...

Nasdaq, Inc. recently reported its December 2025 trading volumes and Q4 operational metrics, while also setting January 29, 2026, for its fourth-quarter and full-year 2025 earnings release and investor conference call, which will feature senior management commentary and Q&A. These disclosures, alongside increased equity trading activity and expanding technology offerings such as Verafin and broader fintech solutions, have intensified attention on how Nasdaq’s business mix and transaction...

If you are wondering whether Under Armour at around US$5.64 is a bargain or a value trap, you are not alone. The answer depends heavily on how you look at its valuation. The stock has recently shown sharp moves, with a 6.6% return over the last week and 28.8% over the last 30 days, against a 6.6% return year to date and longer term returns of a 31.3% decline over 1 year, a 50.9% decline over 3 years, and a 68.8% decline over 5 years. Recent headlines have focused on Under Armour's brand...

Iovance Biotherapeutics (IOVA) recently told investors it expects to meet its 2025 revenue guidance of US$250 million to US$300 million, while surpassing 1,000 patients treated with its tumor infiltrating lymphocyte therapies globally. See our latest analysis for Iovance Biotherapeutics. The revenue guidance update and patient milestone come after a mixed stretch for investors, with the share price at US$2.45 and a 1-month share price return of 8.89% and a 90-day share price return of 16.67%,...

If you are wondering whether Tesla's share price still makes sense for you at today's levels, the key question is what you are really paying for when you buy the stock. Tesla last closed at US$445.01, with returns of 1.6% over the past week, a 0.4% decline over the past month, 1.6% year to date and 12.7% over the last year, while the 3 year and 5 year returns sit at 263.6% and 61.6% respectively. Recent headlines around Tesla have continued to focus on its role as a major electric vehicle...

Lamb Weston Holdings has already moved to close its Munro, Argentina plant and consolidate Latin American production at its newer Mar del Plata facility, while temporarily curtailing a production line in the Netherlands as part of its Focus to Win cost-efficiency program. This reshaping of its international manufacturing footprint highlights how the company is leaning on plant consolidation and capacity adjustments to pursue margin and efficiency gains across its global network. We’ll now...

Ameris Bancorp (ABCB) is back on investors’ radar after recent trading, with the stock last closing at $79.13 and showing positive total returns over the past year, past 3 months, and month. See our latest analysis for Ameris Bancorp. The recent share price move to $79.13 comes on top of a 6.96% 7 day share price return and a 34.75% 1 year total shareholder return, which suggests momentum is building rather than fading. If Ameris Bancorp has caught your attention, it could be a good moment to...

If you are wondering whether Lindsay's share price reflects its underlying worth, you are not alone. This article walks through what the current market price might be telling you about value. Lindsay recently closed at US$125.14, with returns of 3.3% over the past week, 2.6% over the last 30 days, 3.3% year to date, 2.8% over 1 year, and longer term returns of an 18.7% decline over 3 years and a 4.7% decline over 5 years. Recent company updates around operations, capital allocation or sector...

In recent days, Fiverr International’s shares fell even as the broader market advanced, ahead of an upcoming earnings report expected to show higher earnings per share and modest revenue growth. Analysts currently rate the stock as a Hold and highlight a forward price-to-earnings multiple below the industry average, raising questions about whether investors are discounting the company’s expected growth or factoring in elevated uncertainty. With the stock under pressure despite forecasts for...

Fluor Corporation recently achieved mechanical completion on BASF’s Zhanjiang Verbund project in China, delivering wide-ranging engineering, procurement, and construction scope with more than 75 million work hours recorded without a Lost Time Injury. This milestone reinforces Fluor’s capability to execute complex, integrated industrial sites at scale while maintaining rigorous safety performance across a workforce that peaked at about 13,000 people. We’ll now explore how this large, safely...

Why Service Corporation International Is Back on Investors’ Radar Service Corporation International (SCI) is drawing attention after recent commentary flagged two years of flat funeral service volumes, softer free cash flow margins, and a declining return on invested capital. Taken together, these metrics are raising questions about the stock’s recent move. See our latest analysis for Service Corporation International. Against that backdrop, SCI’s share price has been relatively steady, with...

If you are wondering whether Lakeland Financial is attractively priced or not, this article walks through what the current numbers might be telling you about the stock. The share price recently closed at US$57.13, with returns of 1.2% over the past week, a 3.7% decline over the past month, 1.2% year to date and a 10.6% decline over the last year, which can shape how investors think about both opportunity and risk. These moves sit against a backdrop of ongoing sector wide attention on...

If you are looking at Rithm Capital and wondering whether the current share price offers value, this article will walk you through what the numbers are really saying about the stock. Rithm Capital's share price closed at US$11.57 recently, with returns of 5.4% over the past week, 3.2% over the past month, 5.4% year to date, 18.2% over one year, 74.2% over three years and 100.1% over five years. These figures naturally raise questions about how the current price compares with the company’s...

In recent days, Tecnoglass, a Colombia-based glass and window manufacturer listed on the NYSE, issued full-year EBITDA guidance that disappointed investors, while competitor Apogee Enterprises reported weaker-than-expected third-quarter results and reduced its fiscal 2026 outlook due to softer demand and higher costs. This combination of cautious outlooks has heightened concerns about sector-wide volume and cost pressures, prompting investors to reassess the resilience of Tecnoglass’s...

If you have been wondering whether UL Solutions is priced attractively right now, you are not alone. The stock has drawn attention from investors who are trying to work out what a fair value might look like. The share price last closed at US$84.38, with reported returns of 4.3% over the past week, 9.5% over the past month, and 72.5% over the past year. This naturally raises questions about what is already reflected in the price. Recent coverage has focused on UL Solutions as a newly listed...

PAR Technology (PAR) is back in focus after 10% shareholder Voss Capital deployed about US$7.1 million to buy 196,040 additional shares, alongside new CEO participation at the upcoming Needham Growth Conference. See our latest analysis for PAR Technology. Recent insider buying and the upcoming Needham Growth Conference appearance come after a mixed run. The share price has returned 4.6% year to date, but the 1 year total shareholder return is down 44.9%, suggesting sentiment is still in...

In December 2025, Live Oak Bancshares disclosed a material weakness in its internal controls over financial reporting, announced plans to restate prior-period financial statements due to cash flow misclassifications, and signaled that earlier filings should no longer be relied upon, while also scheduling its fourth quarter 2025 results release and conference call for January 21–22, 2026. The disclosure has already prompted a securities law investigation by Pomerantz LLP and coincided with...

If you are looking at Franklin Resources and wondering whether its current share price offers good value, the first step is to separate short term excitement from a clear view of what the business might be worth. The stock last closed at US$25.66, with returns of 7.8% over the past week, 10.1% over the past month, 7.8% year to date, 42.2% over the past year, 0.1% over three years and 23.0% over five years, which may have caught the attention of investors watching for changing risk and return...

The U.S. Supreme Court’s decision to delay a ruling on tariff legality has brought tariffs back into focus for import-heavy retailers, with Kohl's (KSS) seeing its shares fall about 5% on the news. See our latest analysis for Kohl's. Beyond today’s tariff driven setback, Kohl’s recent 30 day share price return of a 13.08% decline contrasts with a strong 46.92% 90 day share price gain and a 56.44% 1 year total shareholder return, suggesting momentum has cooled after a strong run. If tariffs...

In recent days, Ocular Therapeutix has drawn attention as analysts emphasized its expanding pipeline of hydrogel-based eye therapies, including AXPAXLI for wet age-related macular degeneration and PAXTRAVA for glaucoma, against a backdrop of declining revenue and a short cash runway. Investors now appear to be weighing the company’s significant projected revenue growth from next-generation retinal treatments against the heightened risk that future capital raises could dilute existing...